Rhythm Pharmaceuticals (RYTM) Stock: Buy, Sell, or Hold?
RYTM - Rhythm Pharmaceuticals, Inc. Common Stock
$90.78
1.14 (1.27%)
▲
5d:
-2.21%
30d:
-11.17%
90d:
-15.55%
HOLD
LOW Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 03, 2026
22d
Get Alerted When RYTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RYTM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RYTM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RYTM is currently trading at $90.78, which is considered oversold relative to its 30-day fair value range of $93.31 to $103.16.
Technical Outlook: Technically, RYTM is in a uptrend. Immediate support is located at $87.01, while resistance sits at $99.15.
Market Sentiment: RYTM scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $138.82 (+52.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RYTM is in a uptrend. Immediate support is located at $87.01, while resistance sits at $99.15.
Market Sentiment: RYTM scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $138.82 (+52.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$93.31 -
$103.16
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
Protect Your Profits
Holding RYTM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 52.9% below Wall St target ($138.82)
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$93.31 -
$103.16
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$87.01
Resistance Level
$99.15
Current Trend
Uptrend
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-171.80
Wall Street Target
$138.82
(+52.9%)
Revenue Growth (YoY)
46.9%
Profit Margin
-85.6%
Share & Embed Analysis
Last updated: October 10, 2026 9:42 PM ET
Data refreshes hourly during market hours. Next update: 10:42 PM
Data refreshes hourly during market hours. Next update: 10:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RYTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
27 analysts |
$853 | 52 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$32 | 63 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 36 SELL |
|
PHVS
Pharvaris BV |
STRONG BUY
14 analysts |
$57 | 69 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
19 analysts |
$644 | 45 HOLD |
Advanced RYTM Option Strategies
Professional options setups generated by AI based on today's RYTM price and gamma walls.
